# Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania

> **NCT04953130** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 10400 (estimated)

## Conditions studied

- HPV Infection
- Vaccine Preventable Disease

## Interventions

- **BIOLOGICAL:** Gardasil® HPV vaccine

## Key facts

- **NCT ID:** NCT04953130
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-01
- **Primary completion:** 2025-11
- **Final completion:** 2026-10
- **Target enrollment:** 10400 (ESTIMATED)
- **Last updated:** 2025-09-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04953130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04953130, "Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04953130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*